Related Experiment Video
Updated: Dec 31, 2025
05:16
Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors
Published on: February 19, 2022
6.4K
Report from the 20th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan;
Current Oncology (Toronto, Ont.)
|January 4, 2020
Summary
This consensus statement provides updated recommendations for managing colorectal cancer, based on the 20th annual Western Canadian Gastrointestinal Cancer Consensus Conference. It reflects expert consensus among multidisciplinary health professionals involved in gastrointestinal cancer care.
Area of Science:
- Gastroenterology and Oncology
- Multidisciplinary Cancer Care
Background:
- The 20th annual Western Canadian Gastrointestinal Cancer Consensus Conference convened in Saskatoon, Saskatchewan, on September 28-29, 2018.
- This conference brought together healthcare professionals from Western Canada (British Columbia, Alberta, Saskatchewan, Manitoba) and invited speakers from other provinces.
- Participants included surgical, medical, and radiation oncologists, alongside allied healthcare professionals focused on gastrointestinal cancer patient care.
Framework:
- The conference employed an interactive, multidisciplinary format.
- Presentations and discussion sessions facilitated the development of consensus-based recommendations.
- The primary focus was on addressing current issues in the management of colorectal cancers.
Implementation:
- Recommendations were developed through collaborative expert discussion.
- The consensus statement synthesizes current best practices and emerging issues.
- The multidisciplinary approach ensures comprehensive consideration of patient management strategies.
Implications:
- Provides evidence-based guidelines for colorectal cancer management.
- Enhances the quality of care for patients with gastrointestinal cancers in Western Canada.
- Facilitates standardized and optimal treatment approaches through shared expertise.
Keywords:
Colorectal canceradjuvant radiation therapybiomarkerscytoreductive surgeryhipeclocal excisionmolecular testsrectal cancersidednesssurgerysurveillancetotal neoadjuvant treatmentMore Related Videos
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
264
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
264
01:21Inflammatory Bowel Disease V: Surgical Management
403
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
403
02:56Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
03:03mTOR Signaling and Cancer Progression
4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.5K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
589
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
589